OrganiGram
6
5M
4
0.43
2
0.33
- Areas of investment
Summary
OrganiGram appeared to be the Corporate Investor, which was created in 2013. The leading representative office of defined Corporate Investor is situated in the Moncton. The fund was located in North America if to be more exact in Canada.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Cannabis. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the various public portfolio startups of the fund, we may underline Hyasynth Bio
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2018.
The usual cause for the fund is to invest in rounds with 1 partaker. Despite the OrganiGram, startups are often financed by SOSV, RebelBio, InnoStart Capital.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 2
- Rounds per year
- 0.43
- Follow on index
- 0.33
- Investments by industry
- Cannabis (5)
- Biotechnology (4)
- Biopharma (4)
- Pharmaceutical (3)
- Manufacturing (2) Show 7 more
- Investments by region
-
- Canada (4)
- United States (2)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.17
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Green Tank Technologies | 31 Mar 2023 | Manufacturing, Product Design, Hardware | Early Stage Venture | 14M | Ontario, Old Toronto, Canada |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.